The antioxidant properties of captoprilDOBRUCKI, R; RADOMSKA, A; ZGOŁA, W et al.Pharmazie. 1996, Vol 51, Num 12, issn 0031-7144, p. 992Article

Clinical efficacy of sublingual captopril in the treatment of hypertensive urgencyKAZERANI, H; HAJIMORADI, B; AMINI, A et al.Singapore medical journal. 2009, Vol 50, Num 4, pp 400-402, issn 0037-5675, 3 p.Article

Antioxidant power of angiotensin-converting enzyme inhibitors in vitroBENZIE, I. F. F; TOMLINSON, B.British journal of clinical pharmacology. 1998, Vol 45, Num 2, pp 168-169, issn 0306-5251Article

Study and analytical application of inhibitory effect of captopril on multienzyme redox systemYAHONG CHEN; RUXIU CAI.Talanta (Oxford). 2003, Vol 61, Num 6, pp 855-861, issn 0039-9140, 7 p.Article

Vitamin D inhibits captopril-induced cell detachment and apoptosis in keratinocytesZEELI, T; LANGBERG, M; ROTEM, C et al.British journal of dermatology (1951). 2011, Vol 164, Num 1, pp 62-67, issn 0007-0963, 6 p.Article

Fotosensibilización por captopril = Fotosensitization to captoprilVILAPLANA, J; ROMAGUERA, C; LECHA, M et al.Medicina cutánea ibero-latino-americana. 1996, Vol 24, Num 4, pp 167-169, issn 0210-5187Article

CENTRAL ANGIOTENSIN CONVERTING ENZYME BLOCKADE AND THIRSTDI NICOLANTONIO R; MENDELSOHN FAO; HUTCHINSON JS et al.1983; PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR; ISSN 0091-3057; USA; DA. 1983; VOL. 18; NO 5; PP. 731-735; BIBL. 28 REF.Article

PHARMACOLOGIE DES INHIBITEURS DE L'ENZYME DE CONVERSION (CAPTOPRIL ET PRODUITS APPARENTES)PLOUIN PF; SCHWEBIG A; ALHENC GELAS F et al.1982; REV. PRAT.; ISSN 0035-2640; FRA; DA. 1982; VOL. 32; NO 1; PP. 65-73; 7 P.; ABS. ENG; BIBL. 20 REF.Article

LONG-TERM TREATMENT OF BARTTER'S SYNDROME WITH CAPTOPRILHENE RJ; KOOMANS HA; BOER P et al.1982; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6343; PP. 695; BIBL. 5 REF.Article

Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNACHEN, H; MOHUCZY, D; LI, D et al.Gene therapy (Basingstoke). 2001, Vol 8, Num 10, pp 804-810, issn 0969-7128Article

Maltodextrins as new chiral selectors in the design of potentiometric, enantioselective membrane electrodesSTEFAN, Raluca-Ioana; VAN STADEN, Jacobus Koos F; ABOUL-ENEIN, Hassan Y et al.Fresenius' journal of analytical chemistry. 2001, Vol 370, Num 1, pp 33-37, issn 0937-0633Article

Solid-state trans-cis isomerization of captopril determined by thermal Fourier transform infrared (FT-IR) microspectroscopyWANG, Shun-Li; LIN, Shan-Yang; CHEN, Ting-Fang et al.Journal of pharmaceutical sciences. 2001, Vol 90, Num 8, pp 1034-1039, issn 0022-3549Article

Inhibition of angiogenesis in Kaposi's sarcoma by captoprilVOGT, B; FREY, F. J.Lancet (British edition). 1997, Vol 349, Num 9059, issn 0140-6736, p. 1148Article

Treatment of infantile haemangioma with captoprilTAN, S. T; ITINTEANG, T; DAY, D. J et al.British journal of dermatology (1951). 2012, Vol 167, Num 3, pp 619-624, issn 0007-0963, 6 p.Article

Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and LosartanBEN HENDA, Yesmine; LABIDI, Anis; ARNAUDIN, Ingrid et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 45, pp 10685-10690, issn 0021-8561, 6 p.Article

Enzymatic resolution of methyl DL-β-acetylthioisobutyrate and DL-β-acetylthioisobutyramide using a stereoselective esterase from Pseudomonas putida IFO12996SHAW, Shyh-Yu; CHEN, Yu-Jen; OU, Jung-Jung et al.Journal of molecular catalysis. B, Enzymatic. 2006, Vol 38, Num 3-6, pp 163-170, issn 1381-1177, 8 p.Article

Inclusion complex formation of captopril with α- and β-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studiesIKEDA, Yoichi; MOTOUNE, Sohko; MATSUOKA, Toshikazu et al.Journal of pharmaceutical sciences. 2002, Vol 91, Num 11, pp 2390-2398, issn 0022-3549, 9 p.Article

Determination and Applications of the Molar Absorptivity of Phenolic Adducts with Captopril and MesnaGARCIA-MOLINA, F; MUNOZ-MUNOZ, J. L; GARCIA-MOLINA, M et al.Journal of agricultural and food chemistry (Print). 2009, Vol 57, Num 4, pp 1143-1150, issn 0021-8561, 8 p.Article

Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblastsYU YU LIU; WEI MIN YAO; TIE WU et al.Journal of bone and mineral metabolism (English ed.). 2011, Vol 29, Num 2, pp 149-158, issn 0914-8779, 10 p.Article

Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silicaFENGYU QU; GUANGSHAN ZHU; SHIYING HUANG et al.Microporous and mesoporous materials. 2006, Vol 92, Num 1-3, pp 1-9, issn 1387-1811, 9 p.Article

Allylmercaptocaptopril: A new antihypertensive drugMIRON, Talia; RABINKOV, Aharon; PELEG, Edna et al.American journal of hypertension. 2004, Vol 17, Num 1, pp 71-73, issn 0895-7061, 3 p.Article

EXFOLIATIVE DERMATITIS FROM CAPTOPRILSOLINGER AM.1982; CUTIS; USA; DA. 1982; VOL. 29; NO 5; PP. 473-474; BIBL. 6 REF.Article

REVERSAL OF SCLERODERMA RENAL CRISIS FOR MORE THAN TWO YEARS IN A PATIENT TREATED WITH CAPTOPRILSORENSEN LB; PAUNICKA K; HARRIS M et al.1983; ARTHRITIS AND RHEUMATISM; ISSN 0004-3591; USA; DA. 1983; VOL. 26; NO 6; PP. 797-800; BIBL. 13 REF.Article

CONVERTING ENZYME INHIBITION: A NOVEL CONCEPT IN DRUG THERAPY OF HYPERTENSIONGIESE J; RASMUSSEN S.1981; EUR. J. CLIN. INVEST.; ISSN 0014-2972; GBR; DA. 1981; VOL. 11; NO 5; PP. 341-343; BIBL. 22 REF.Article

EVIDENCE FOR A DUAL ACTION OF CONVERTING ENZYME INHIBITOR ON BLOOD PRESSURE IN NORMAL MANGOLDSTONE R; MARTIN K; ZIPSER R et al.1981; PROSTAGLANDINS; ISSN 0090-6980; USA; DA. 1981; VOL. 22; NO 4; PP. 587-598; BIBL. 35 REF.Article